Concepedia

Stéphanie Garcia-Acosta

SG

Statistics

Publications

5

Citations

359

H-Index

5

Active since

1999

Affiliations

Institut Gustave Roussy(Current)

Pitié-Salpêtrière Hospital

Sanofi (France)

Sorbonne Université

Stéphanie Garcia-Acosta is an author at Institut Gustave Roussy specializing in pharmacotherapy, withdrawal syndromes, and clinical pharmacology.

Publications per year

1999–2005

5

Publications

5

Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome

Patrick Lemoine, Imane Kermadi, Stéphanie Garcia-Acosta et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2005 · 181 citations

, , +9

Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole

C. Paillisse, Lucette Lacomblez, Michel Dib et al. · Amyotrophic Lateral Sclerosis · 2005 · 106 citations

, , +17

[Dealing with missing, abnormal and incoherent data in E3N cohort study].

Stéphanie Garcia-Acosta, Françoise Clavel‐Chapelon · PubMed · 1999 · 27 citations

, , +10

Patient preference for either the EORTC QLQ-C30 or the FACIT Quality Of Life (QOL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP)

C Rodary, V. Pezet-Langevin, Stéphanie Garcia-Acosta et al. · European Journal of Cancer · 2004 · 26 citations

, , +16

Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome

J.D. Favre, H. Allain, Henri‐Jean Aubin et al. · Human Psychopharmacology Clinical and Experimental · 2005 · 19 citations

, , +12

1–5 of 5